KNIGHT THERAPEUTICS INC (GUD.CA) Forecast, Price Target & Analyst Ratings

Name: KNIGHT THERAPEUTICS INC (GUD.CA) Analyst Consensus Rating
Brand: KNIGHT THERAPEUTICS INC
Rating: 8 (10 reviews)

TSX:GUD • CA4990531069

7.2 CAD

+0.12 (+1.69%)

Last: Mar 27, 2026, 07:00 PM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for KNIGHT THERAPEUTICS INC (GUD.CA).

Consensus Price Target

Price Target

CA$8.36

+ 16.05% Upside

→ Price target details

Next Earnings Forecast

Earnings Estimate

Release Date: May 6, 2026
Period: Q1 / 2026
EPS Estimate: CA$0.03
Revenue Estimate: 113.62M

→ Full earnings forecast details

ChartMill Buy Consensus

Rating

78.00%

Weighted Analyst Rating Score

→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target

CA$8.36

Upside

+ 16.05%

From current price of CA$7.20 to mean target of CA$8.36, Based on 10 analyst forecasts

Low

CA$6.21

Median

CA$8.16

High

CA$11.55

Price Target Revisions

1 Month

3.26%

3 Months

4.07%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for GUD.CA. The average price target is 8.36 CAD. This implies a price increase of 16.05% is expected in the next year compared to the current price of 7.2.

The average price target has been revised upward by 4.07% in the past 3 months.

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

Analyst Ratings History

Analyst Ratings Consensus

ChartMill Buy Consensus

78.00%

GUD.CA was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about GUD.CA.

In the previous month the buy percentage consensus was at a similar level.

GUD.CA was analyzed by 10 analysts. More opinions would make the average more meaningful.

→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Date	Firm	Action	From → To
2022-08-12	Stifel Nicolaus Research	Upgrade
2022-08-12	National Bank of Canada Financial	Upgrade	Outperform
2022-03-28	Bloom Burton	Initiate	Buy
2022-03-26	Bloom Burton	Downgrade	Buy -> Accumulate
2022-03-25	Raymond James Capital	Downgrade	Outperform
2022-03-25	National Bank of Canada Financial	Downgrade	Outperform
2022-03-25	Canaccord Capital	Upgrade	Buy
2022-03-25	National Bank Financial	Downgrade	Outperform
2021-11-12	RaymondJamesFinancial	Initiate	Outperform
2021-11-12	NationalBankFinancial	Upgrade	Outperform
2021-09-24	Raymond James Financial	Initiate	Outperform
2021-08-17	Raymond James Financial	Initiate	Outperform
2021-07-13	RBC Capital	Initiate	Outperform
2021-05-17	Raymond James Financial	Initiate	Outperform
2021-04-26	National Bank Financial	Upgrade	Outperform
2021-04-26	Raymond James Financial	Upgrade	Outperform
2021-03-27	Bloom Burton	Upgrade	Accumulate -> Buy
2021-03-26	Raymond James Financial	Initiate	Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date: May 6, 2026
Period: Q1 / 2026
EPS Estimate: CA$0.03
Revenue Estimate: 113.62M
Revenue Q2Q: 29.00%
EPS Q2Q: 34.68%
Number of Analysts: 4

Next Earnings Revisions

Revenue (1 Month)

N/A

Revenue (3 Months)

N/A

EPS (1 Month)

N/A

EPS (3 Months)

N/A

Next Earnings Summary

GUD.CA is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is 0.03 CAD and the consensus revenue estimate is 113.62M CAD.

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

	2023	2024	2025	2026	2027	2028	2029	2030
Revenue YoY % growth	328.199M 11.80%	371.304M 13.13%	450.088M 21.22%	474.07M 5.33%	482.55M 1.79%	557.25M 15.48%	583.41M 4.69%	635.05M 8.85%
EBITDA YoY % growth	60.097M 31.90%	64.259M 6.93%	61.693M -3.99%	66.17M 7.26%	64.341M -2.76%	89.379M 38.91%	99.713M 11.56%	116.11M 16.44%
EBIT YoY % growth	9.7M 156.86%	11.15M 14.95%	5.124M -54.04%	-6.666M -230.09%	12.807M 292.12%	34.52M 169.54%	48.885M 41.61%	68.843M 40.83%
Operating Margin	2.96%	3.00%	1.14%	-1.41%	2.65%	6.19%	8.38%	10.84%
EPS YoY % growth	-0.16 38.46%	0.05 131.25%	-0.04 -180.00%	0.05 219.94%	0.14 194.74%	0.36 151.29%	0.44 24.67%	0.56 26.65%

All data in CAD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

	Q1 / 26	Q2 / 26	Q3 / 26	Q4 / 26
EPS Q2Q % growth	0.03 34.68%	0.04 128.49%	0.05 352.50%	0.07 -25.18%
Revenue Q2Q % growth	113.62M 29.00%	126.29M 17.63%	131.38M 8.09%	135.25M 1.61%
EBITDA Q2Q % growth	16.267M 169.01%	18.397M -13.88%	20.26M -55.18%	21.213M -67.54%
EBIT Q2Q % growth	10.525M 290.08%	12.821M 643.49%	15.565M 318.98%	14.796M 68.39%

All data in CAD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year

121.61%

EPS Next 5 Year

74.17%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year

8.29%

Revenue Next 5 Year

7.67%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year

83.95%

EBIT Next 5 Year

51.89%

→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

KNIGHT THERAPEUTICS INC / GUD.CA Forecast FAQ

What do analysts expect the price target to be for KNIGHT THERAPEUTICS INC (GUD.CA)?

10 analysts have analysed GUD.CA and the average price target is 8.36 CAD. This implies a price increase of 16.05% is expected in the next year compared to the current price of 7.2.

What is the next earnings date for GUD stock?

KNIGHT THERAPEUTICS INC (GUD.CA) will report earnings on 2026-05-06.

What are the consensus estimates for GUD stock next earnings?

The consensus EPS estimate for the next earnings of KNIGHT THERAPEUTICS INC (GUD.CA) is 0.03 CAD and the consensus revenue estimate is 113.62M CAD.

What is the consensus rating for KNIGHT THERAPEUTICS INC (GUD.CA) stock?

The consensus rating for KNIGHT THERAPEUTICS INC (GUD.CA) is 78 / 100 . This indicates that analysts generally have a positive outlook on the stock.

Analyst forecast overview

Forecast Snapshot